SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The Board adopted a Nonqualified Deferred Compensation Plan for named executive officers and directors, and entered into a consulting agreement with Dr. Rebecca Taub (Class II director) providing $100,000 annually plus director compensation. These compensatory arrangements were approved by stockholders as part of the Annual Meeting voting on the 2026 Stock Plan and 2026 Employee Stock Purchase Plan.
View raw filing on EDGAR →The 6-K discloses a grant of options under the "Foundation Plan for Growth" to 12 PDMRs (persons discharging managerial responsibilities), including the CEO, CFO, and other named executives. The announcement details the vesting conditions (50% after three years, 50% after four years, subject to TSR performance), exercise prices, and aggregate grant values (totaling approximately €109.8 million across all recipients). This is a material compensatory arrangement affecting senior executives' equity interests, falling squarely within exec_compensation disclosure requirements under Market Abuse Regulation 596/2014.
View raw filing on EDGAR →The exhibit discloses equity compensation grants to directors, officers, employees, and consultants: 201,969 stock options at $2.30 per share and 266,035 restricted share units, approved by the Board on June 11, 2026, with three-year vesting schedules. While the press release also announces receipt of a $50,000 government grant for exploration (operational/financial), the substantive disclosure requiring classification under 8-K Item 5.02(e) standards is the equity award grant, which is material to investors assessing management incentive alignment and potential dilution.
View raw filing on EDGAR →The filing discloses a material compensatory arrangement: the Board approved a grant of 271,076 performance-based restricted stock units (PSUs) to CEO Dr. KR Sridhar on June 15, 2026, under the 2018 Equity Incentive Plan. The award is conditioned on objective revenue and margin targets through 2029 and includes a holding requirement through 2031, designed to retain the CEO and align his incentives with strategic growth priorities. This is a classic equity compensation disclosure under Item 5.02(e).
View raw filing on EDGAR →The filing discloses Compensation Committee approval of annual base salary adjustments for three named executives: Louis Hoch (CEO) at $995,000, Greg Carter (SVP, Chief Accounting Officer) at $325,000, and Michael White (SVP, Chief Accounting Officer) at $260,000, all effective August 3, 2026. This is a direct disclosure of compensatory arrangements under Item 5.02(e), which is material to investors assessing executive compensation practices.
View raw filing on EDGAR →The disclosure centers on the Compensation Committee's approval of equity awards (1,961,986 PSUs and 783,618 RSUs) granted to executive officers including the CEO, CFO, and Chief Accounting Officer under the 2026 Equity Incentive Plan. This is a classic compensatory arrangement disclosure under Item 5.02(e), with specific vesting schedules and performance targets tied to stock price appreciation over three years. The awards represent 37% of authorized shares and are material to investor assessment of executive compensation.
View raw filing on EDGAR →The Compensation Committee approved and adopted the Senior Executive Annual Bonus Plan on June 15, 2026, establishing a compensatory arrangement for executive officers and designated employees. The plan specifies performance metrics, payment mechanisms (cash or stock under the 2022 Equity Incentive Plan), and clawback provisions. This is a material disclosure of a new compensation plan affecting executive officers, fitting squarely within the exec_compensation category.
View raw filing on EDGAR →The filing discloses a letter agreement with Stavros Vizirgianakis, the Chairman, in connection with his appointment as Executive Chairman. The material substance is the Board's approval of a 450,000 RSU grant under the 2023 Share Incentive Plan with a three-tranche vesting schedule. While the appointment itself is mentioned, the filing centers on the compensatory arrangement—the equity grant—which is the principal disclosed action and would materially affect investor assessment of executive compensation and dilution.
View raw filing on EDGAR →Urban One entered into a new employment agreement with CFO Peter D. Thompson establishing comprehensive compensatory arrangements including a $750,000 base salary, $333,333 signing bonus, annual performance bonuses up to $300,000, a $850,000 completion bonus contingent on remediation of material weaknesses, and stock-based compensation grants totaling over $1.8 million through January 6, 2029.
View raw filing on EDGAR →Kanzhun granted 550,498 RSU share awards to 45 employees on June 15, 2026, pursuant to the Post-IPO Share Scheme, with vesting schedules ranging from 2–4 years, performance targets covering 84.87% of awards, and clawback provisions.
View raw filing on EDGAR →The disclosure centers on an Amended and Restated Employment Agreement with Chad Cowan, Ph.D., the Chief Scientific Officer, modifying his compensation structure to part-time status with a reduced annual salary of $296,150 and pro-rated performance-based bonus eligibility. While the agreement also addresses termination provisions, the principal disclosed action is a compensatory arrangement modification for a named executive officer, which falls squarely within exec_compensation rather than exec_departure (no departure occurred) or exec_appointment (no new role assumed).
View raw filing on EDGAR →Shareholders approved an amended and restated 2013 Performance Incentive Plan that increases the share pool by 8.8 million shares (from 48.0 to 56.8 million) and extends the plan expiration to 2036, materially expanding equity award capacity for officers, directors, and employees.
View raw filing on EDGAR →The primary disclosure in Item 5.02 is the Board-approved compensation increase for CFO Tiago Miranda, effective immediately, including a base salary increase to $360,000 (retroactive to May 29, 2026), a cash bonus opportunity of up to $120,000, RSU grants valued at $480,000 vesting over four years, and a $20,000 one-time bonus. While Item 8.01 also discloses resolution of Brazilian litigation regarding a community consultation, the filing's substantive focus and Item 5.02 designation center on the executive compensation arrangement reflected in the Amended and Restated Employment Agreement.
View raw filing on EDGAR →The disclosure centers on a new employment agreement with Charles Schoch, the CFO, setting forth compensatory arrangements including base salary ($468,600), annual bonus (40% target), severance provisions (nine months base plus target bonus), COBRA continuation, and equity acceleration upon change of control. This is a classic executive compensation arrangement disclosure under Item 5.02(e), material because it establishes the CFO's compensation terms and change-of-control protections.
View raw filing on EDGAR →The news release announces the grant of 750,000 incentive stock options to "certain directors and officers" pursuant to the Company's Stock Option Plan, with an exercise price of $0.55 per share and a 5-year term. This is a compensatory arrangement for named executives and directors, falling squarely within the exec_compensation category. The grant is material as it represents a significant equity incentive to leadership.
View raw filing on EDGAR →Shareholders approved an amendment to the Company's 2014 Share Incentive Plan to increase the number of ordinary shares reserved for issuance, effective June 10, 2026. This amendment expands the equity compensation pool available for directors and officers.
View raw filing on EDGAR →The disclosure centers on an amendment to Jillian C. Evanko's Senior Advisor Agreement that modifies compensatory arrangements, including a termination date and fixed fee structure. While the amendment also contemplates the eventual end of her advisory services, the substantive disclosure focuses on the modification of compensation terms and conditions, making this primarily an exec_compensation event rather than a departure.
View raw filing on EDGAR →The disclosure describes establishment of a formal compensation plan for non-employee directors, specifying annual cash compensation ($100,000) and equity grants (750 restricted shares). This is a compensatory arrangement for directors that would materially affect investor assessment of governance and executive costs. While filed under Item 1.01 (typically for M&A), the substance is director compensation plan adoption, which falls under exec_compensation.
View raw filing on EDGAR →Stockholders approved an amendment to the 2023 Incentive Compensation Plan increasing authorized shares from 138,861 to 520,000 and raising the annual non-employee director award limit from 2,500 to 75,000 shares, materially expanding equity grant capacity for executives and directors.
View raw filing on EDGAR →Stockholders approved an amendment to the 2024 Equity Incentive Plan increasing available shares by 1,600,000 shares (approximately 3.1% of outstanding common shares), expanding the pool of equity available for grants to officers and directors.
View raw filing on EDGAR →The filing discloses two material events under Item 5.02 and Item 5.07. The primary substantive disclosure is the Compensation Committee's approval on June 11, 2026 of an increase to CEO Vininder Singh's annual base salary from $400,000 to $600,000 (a 50% increase) and modification of his target annual bonus to a maximum of 50% of base salary. While the filing also reports shareholder vote results (Item 5.07), the compensation arrangement is the more significant material event requiring disclosure, as it represents a substantial change to executive compensation that would affect investor assessment of the company's cost structure and executive incentives.
View raw filing on EDGAR →The disclosure centers on amendments to Adam K. Bowen's compensatory and employment arrangements as Interim CFO, including modifications to base salary, bonus structure, discretionary cash awards ($100,000 initial plus conditional quarterly awards), and LTI equity vesting terms. While the filing is under Item 5.02, the substantive focus is on compensation modifications rather than a departure or appointment event, making exec_compensation the most precise classification.
View raw filing on EDGAR →Adoption of amended and restated equity incentive plans (the A&R 2024 Plan and Second A&R ESPP) in connection with the Company's IPO, establishing the framework for compensatory equity awards to directors, officers, and employees with hundreds of millions of shares reserved.
View raw filing on EDGAR →Shareholders approved the Fourth Amended and Restated 2019 Incentive Award Plan, which materially expands the equity compensation framework by increasing available shares by 9.45 million and extending the grant period through 2036.
View raw filing on EDGAR →The disclosure centers on compensatory arrangements for Swen Neufeldt, a Group Vice President, including modifications to his base salary structure (addition of $56,103 cost-of-living adjustment), relocation payments ($20,000), housing allowance ($90,566 annually), and various other benefits totaling substantial additional compensation tied to his international assignment. While the assignment itself is administrative, the material substance of the 8-K Item 5.02 filing is the new compensatory package and benefits arrangement.
View raw filing on EDGAR →The Board approved the Annual Incentive Bonus Plan for fiscal 2027 on June 11, 2026, establishing compensatory arrangements for executive officers including target award opportunities (165% of base salary for CEO, 115% for CFO, 100-110% for other NEOs) and performance metrics tied to operating profit, free cash flow, and revenue. This is a classic Item 5.02(e) disclosure of executive compensation plan terms and is material to investors assessing executive incentive structures.
View raw filing on EDGAR →The Compensation Committee approved a form of Restricted Stock Unit Award Agreement under the 2026 Incentive Plan on June 10, 2026. This is a compensatory arrangement for officers and directors involving equity grants, which falls squarely within the exec_compensation category. The approval of a plan form document that will govern future RSU awards is material to investors assessing executive compensation practices.
View raw filing on EDGAR →This announcement discloses a grant of 737,054 RSUs to 302 employees under the Company's 2021 Plan on June 12, 2026. The disclosure details the vesting schedules, market prices, clawback mechanisms, and the Board's rationale for the grants as a compensation and retention mechanism. This is a material compensatory arrangement for employees that affects the Company's capital structure and incentive programs, consistent with Item 5.02(e) disclosure of executive and employee compensation arrangements.
View raw filing on EDGAR →The Board approved material compensatory arrangements for named executives and directors, including base salary increases retroactive to January 1, 2026 for the CEO, CFO, CAO, Controller, and other senior officers, as well as increases to annual equity target opportunities ranging from 75% to 400% of base salary and equity compensation for non-employee directors.
View raw filing on EDGAR →This exhibit is the 2026 Incentive Securities Plan adopted by Neo-Concept International Group Holdings Ltd on June 12, 2026. It establishes a comprehensive equity compensation framework allowing the Board to grant options, restricted share units, share appreciation rights, and restricted share awards to employees, directors, consultants, and sub-contractors. The plan reserves 472,856 shares for issuance and sets forth detailed terms for vesting, exercise, and performance criteria. This is a material disclosure of compensatory arrangements that would affect investor assessment of executive and employee incentive structures.
View raw filing on EDGAR →Stockholders approved an amendment and restatement of the 2021 Stock Incentive Plan, which affects equity grants and awards across the company. A director reclassification (Curran's transition from Class II to Class III) was also disclosed but is administrative in nature.
View raw filing on EDGAR →The filing discloses Board approval of base salary ($300,000) and target bonus (40% of base salary) for Ross Ridenoure, Chief Nuclear Officer, following the company's business combination closing. This is a compensatory arrangement disclosure under Item 5.02(e), establishing initial compensation terms for an executive officer in his post-closing role. The materiality reflects that executive compensation arrangements are material to investors assessing management incentives and cost structure.
View raw filing on EDGAR →The filing discloses retention bonus letter agreements entered into on June 10, 2026 with two named executives: Nelson Sun (CFO/COO) receiving $346,500 and Dr. Manasi Jaiman (CMO) receiving $357,000. These are compensatory arrangements—guaranteed annual bonuses and retention bonuses—payable contingent on continued employment or qualifying termination events, which is the hallmark of exec_compensation disclosures under Item 5.02(e).
View raw filing on EDGAR →The filing centers on the grant of performance-based stock option awards to Mitchell P. Rales, Shyam P. Kambeyanda, and other senior management team members. While the section also discloses Rales' appointment as Executive Chair and Jordan's appointment as Lead Independent Director, the substantive disclosure focuses on the design, terms, and vesting conditions of the compensatory arrangements—including stock price hurdles, service vesting periods, and share counts. This is a classic exec_compensation event under Item 5.02(e), material to investors assessing executive incentive alignment and retention strategy.
View raw filing on EDGAR →SAGTEC Global Limited granted supplemental equity-based compensation to three named executive officers in May 2026: CEO Ng Chen Lok (415,000 restricted Class A Ordinary Shares valued at ~USD 387,609), Group CFO Zuria Hajar Binti Mohd Adnan (15,000 shares valued at ~USD 14,001), and CTO Tan Kim Chuan (50,000 shares valued at ~USD 46,700) for 2026 services.
View raw filing on EDGAR →The company approved the 2026 Executive Compensation Plan on February 26, 2026, increasing base salaries by 5% for CEO Steven M. Foster ($420,000), CFO Kevin Williamson ($330,750), and COO Richard Ginn ($304,500), and modified annual bonus opportunities. Additionally, the company amended Richard Ferrari's consulting agreement as Executive Chairman, extending his term through May 6, 2027 at $180,000 annually.
View raw filing on EDGAR →The disclosure centers on a material change to Ms. Conn's compensation arrangement as CFO: her transition to part-time status effective June 29, 2026, with a corresponding salary adjustment to reflect her reduced work schedule. While the filing is captioned Item 5.02 (which covers departures, appointments, and compensation), the principal action disclosed is a compensatory arrangement modification rather than a departure (she remains CFO) or appointment (no new officer is being named). The salary adjustment tied to the role change is the material event.
View raw filing on EDGAR →The filing discloses Board approval of the 2026 Equity Incentive Plan and grants of stock options to named executive officers (Carlos X. Montoya, Ken Park, Brad Hoffman, John Jubilee, and Patrick White) and other employees/service providers. The disclosure details vesting schedules, performance conditions, and exercise prices for equity awards, which constitutes a compensatory arrangement under Item 5.02(e). This is material as it affects executive compensation structure and potential dilution to shareholders.
View raw filing on EDGAR →Avalo Therapeutics amended employment agreements for four named executives (CEO Dr. Neil, CFO Sullivan, CMO Dr. Doyle, and CBO Boyd) to modify severance, change-of-control payments, equity acceleration, and 280G tax gross-up provisions.
View raw filing on EDGAR →The disclosure centers on Amendment No. 1 to Danny Rittman's employment agreement as CTO/CISO, which modifies his compensation through: (1) a base salary increase to $180,000 effective June 1, 2026; and (2) a grant of 1,000,000 performance-based stock options at $4.98/share with milestone-based vesting tied to technical deliverables (VisionRF data room, StratumAI agent release, cybersecurity framework, and EDA strategy room). While the title update is noted, the substantive disclosure is compensatory in nature—salary adjustment and equity grant—making this an exec_compensation event rather than appointment or departure.
View raw filing on EDGAR →The filing discloses equity option grants to named executives and directors under the 2021 Incentive Stock Plan. Ian Bothwell (CEO/CFO), George Shapiro (Chief Medical Officer), and non-executive director Chuck Bretz each received option awards totaling 625,000 to 1,250,000 shares at $1.67 per share. This is a compensatory arrangement for officers and directors, the core subject matter of Item 5.02(e), and materially affects executive compensation structure.
View raw filing on EDGAR →Universal Health Realty Income Trust granted restricted stock awards to four named executive officers on June 10, 2026, with specified share quantities and vesting terms as part of the company's annual long-term incentive compensation program.
View raw filing on EDGAR →The filing's primary focus is the approval of cash retention payments and amended "Change in Control" benefits for named executives (Sapir, Oltmans, Musso) in connection with a restructuring plan following discontinuation of pociredir development. While the section also discloses Greg Tourangeau's departure, the bulk of the disclosure centers on compensatory arrangements—retention bonuses and severance modifications—approved by the compensation committee and board, making exec_compensation the most salient event type.
View raw filing on EDGAR →The filing's principal disclosure under Item 5.02 is an Amended and Restated Compensation Agreement with CEO Kevin O'Donnell, effective June 5, 2026. The agreement specifies a $550,000 annual base salary, a one-time $875,000 cash bonus, elimination of future annual bonus opportunities, and detailed severance and termination provisions. This is a material compensatory arrangement modification for a named executive officer that would affect investor assessment of executive pay and retention incentives.
View raw filing on EDGAR →Shareholders approved the Fifth Amended and Restated 2019 Equity Incentive Plan, increasing authorized shares by 565,000 for equity compensation purposes to officers and directors.
View raw filing on EDGAR →The filing discloses amendments to compensatory arrangements for two named executives: Lachlan K. Murdoch (Executive Chair and CEO) and Steven Tomsic (CFO). The Committee and Board approved increases in target annual bonuses and equity awards for both executives, as well as extensions of their employment terms through June 30, 2030. This is a classic executive compensation disclosure under Item 5.02(e), distinct from a departure or appointment, and is material to investors assessing executive incentive structures and retention.
View raw filing on EDGAR →Stockholders approved an Amended and Restated 2014 Employee Stock Purchase Plan (ESPP) with an increase of 800,000 newly reserved shares, a material compensatory arrangement affecting equity incentives available to employees.
View raw filing on EDGAR →Shareholders approved an amended and restated 2023 Incentive Award Plan that increases shares reserved for issuance by 16.5 million shares and modifies tax withholding provisions, directly affecting equity grant structures for officers and directors.
View raw filing on EDGAR →The Compensation Committee approved a $90,000 cash increase in annual compensation for Jeffrey D. Yowell, the Executive Chairman, effective June 1, 2026, bringing his total annual compensation to $340,000. This is a direct disclosure of a compensatory arrangement modification for a named executive officer, which falls squarely within the exec_compensation category. The materiality is supported by the magnitude of the increase and the fact that it was formally approved by the Committee.
View raw filing on EDGAR →Shareholders approved and the Board adopted the 2026 Equity Incentive Plan, which amends the existing Omnibus Equity Incentive Plan and establishes the framework for future equity compensation grants to officers and directors, effective June 4, 2026.
View raw filing on EDGAR →